Inactive Instrument

Zenyatta Ventures Ltd Share Price Toronto S.E.

Equities

CA98943A1012

Biotechnology & Medical Research

Financials

Sales 2022 0.35 0.47 28.96 Sales 2023 0.07 0.1 6.08 Capitalization 206M 281M 17.18B
Net income 2022 -38M -51.88M -3.17B Net income 2023 -14M -19.11M -1.17B EV / Sales 2022 1,03,15,93,065 x
Net cash position 2022 24.44M 33.37M 2.04B Net cash position 2023 8.75M 11.94M 729M EV / Sales 2023 2,70,79,84,696 x
P/E ratio 2022
-9.19 x
P/E ratio 2023
-14.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 94.07%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 11/18/11
Director of Finance/CFO - 16/22/16
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 05/22/05
Director/Board Member 61 05/23/05
Chief Operating Officer - 11/18/11
More insiders
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
More about the company